BeOne Medicines (ONC) grants director Shalini Sharp 18,980 shares

Rhea-AI Filing Summary

Sharp Shalini reported acquisition or exercise transactions in this Form 4 filing.

BeOne Medicines Ltd. director Shalini Sharp reported a compensation-related equity award. She received 18,980 Ordinary Shares for no cash payment, described as securities underlying restricted share units that vest on the earlier of the first anniversary of the grant date or the next annual general meeting, subject to continued board service and possible accelerated vesting under the company’s Independent Non-Executive Director Compensation Policy. After this award, she directly holds 38,116 Ordinary Shares. A separate line shows direct ownership of 9 American Depositary Shares, with each American Depositary Share representing 13 Ordinary Shares.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Sharp Shalini

Role null

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares	18,980	$0.00	--
holding	American Depositary Shares	--	--	--

Holdings After Transaction: Ordinary Shares — 38,116 shares (Direct, null); American Depositary Shares — 9 shares (Direct, null)

Footnotes (1)

1. Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless there is a triggering event of accelerated vesting pursuant to the Company's Independent Non-Executive Director Compensation Policy. Each American Depositary Share represents 13 Ordinary Shares.

Key Figures

Equity grant: 18,980 Ordinary Shares Total Ordinary Shares held: 38,116 Ordinary Shares ADS holdings: 9 American Depositary Shares +2 more

5 metrics

Equity grant 18,980 Ordinary Shares Grant/award acquisition to director Shalini Sharp at $0.0000 per share

Total Ordinary Shares held 38,116 Ordinary Shares Direct non-derivative holdings after the reported transaction

ADS holdings 9 American Depositary Shares Direct holdings in ADS form following the transaction

ADS-to-Ordinary ratio 1 ADS = 13 Ordinary Shares Conversion ratio stated in Form 4 footnote

Grant price $0.0000 per share Stated transaction price per granted Ordinary Share

Key Terms

restricted share units, American Depositary Share, Independent Non-Executive Director Compensation Policy

3 terms

restricted share units financial

"Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur..."

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

American Depositary Share financial

"Each American Depositary Share represents 13 Ordinary Shares."

An American Depositary Share (ADS) is a U.S.-listed certificate that represents a specified number of shares in a foreign company, held by a custodian bank; it works like a receipt that allows U.S. investors to buy and trade foreign equity on American exchanges without dealing with another country’s markets. Investors care because ADSs make foreign stocks easier to access, improve liquidity and settlement in dollars, and can affect dividend payments, voting rights and regulatory oversight compared with buying the underlying foreign shares directly.

Independent Non-Executive Director Compensation Policy financial

"unless there is a triggering event of accelerated vesting pursuant to the Company's Independent Non-Executive Director Compensation Policy."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sharp Shalini

(Last) (First) (Middle)

C/O BEONE MEDICINES I GMBH

AESCHENGRABEN 27, 21ST FLOOR

(Street)

BASEL 4051

(City) (State) (Zip)

SWITZERLAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
BeOne Medicines Ltd. [ ONC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares(1)	06/11/2026		A		18,980	A	$0	38,116	D
American Depositary Shares(2)								9	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless there is a triggering event of accelerated vesting pursuant to the Company's Independent Non-Executive Director Compensation Policy.

2. Each American Depositary Share represents 13 Ordinary Shares.

Remarks:

	/s/ Qing Nian, as Attorney-in-Fact	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did BeOne Medicines (ONC) report for Shalini Sharp?

BeOne Medicines reported that director Shalini Sharp received 18,980 Ordinary Shares as a grant or award. The shares are tied to restricted share units that vest over time, reflecting compensation rather than an open-market purchase or sale.

How many BeOne Medicines Ordinary Shares does Shalini Sharp hold after this Form 4?

After the reported transaction, Shalini Sharp directly holds 38,116 Ordinary Shares of BeOne Medicines. This reflects her updated equity position following the 18,980-share grant, providing visibility into her total direct non-derivative holdings as a director.

What are the vesting terms of Shalini Sharp’s restricted share units at BeOne Medicines (ONC)?

The restricted share units underlying the 18,980 Ordinary Shares vest fully on the earlier of the first anniversary of the grant date or the next annual general meeting. Vesting stops if she leaves the board, unless accelerated vesting is triggered under the company’s director compensation policy.

How many American Depositary Shares of BeOne Medicines does Shalini Sharp own?

The Form 4 shows that Shalini Sharp directly owns 9 American Depositary Shares of BeOne Medicines. A footnote explains that each American Depositary Share represents 13 Ordinary Shares, linking the ADS position to the company’s underlying Ordinary Shares.

Is Shalini Sharp’s BeOne Medicines Form 4 transaction a market buy or a compensation grant?

The transaction is categorized as a grant, award, or other acquisition of 18,980 Ordinary Shares at a price of $0.0000 per share. Footnote language describing restricted share units and vesting indicates this is compensation-related, not an open-market purchase or sale.

What does each BeOne Medicines American Depositary Share represent in Ordinary Shares?

According to the Form 4 footnote, each American Depositary Share of BeOne Medicines represents 13 Ordinary Shares. This ratio connects ADS holdings reported for insiders to the underlying Ordinary Shares of the company.